UNVEIL
unveil-instruments.com
Actively hiring
Biotechnology
Biologics & Biosimilars
Cell & Gene Therapy
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
IncubAlliance
Momentum
0/100
no fresh signals
Registers and programsofficial lists and records that name the company
| Legal entity | UNVEIL SAS | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
IncubAlliance Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Viral vector CDMO delivering AAV, lentiviral and retroviral vector manufacturing for cell and gene therapy developers from preclinical to…
Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
At Viralgen, we're proud to be known for just one thing: Being a world leader in AAV-based gene therapy manufacturing.. We're all in on…
Discover how Refeyn's mass photometry technologies can rapidly characterize single particles - like proteins and viral vectors - in…
CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia.
SAN FRANCISCO, CA [Jan. 28, 2026] – Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the…
People
Alexis Auchère
Directeur de la publication
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data